Hims & Hers Health, Inc. (HIMS)
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (HIMS 6.96%) may finally be succeeding in cracking the code.
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation
Hims & Hers accelerates European growth with new ZAVA acquisition, adding localized care and lab testing innovation.
Hims & Hers Stock: Buy the Dip or Wait It Out?
One of the most exciting growth stories in the market is that of Hims & Hers Health Inc. NYSE: HIMS. This company has combined the growth and efficiency aspects of the technology sector with the safety and stability of the medical sector.
HIMS Stock Falls Despite Latest Deal to Expand International Footprint
Hims & Hers is set to acquire ZAVA to launch in Germany, France and Ireland, deepening its personalized digital health push.
Why Is Hims & Hers Health (HIMS) Up 10.6% Since Last Earnings Report?
Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock?
Hims & Hers stock price jumps: Telehealth company acquires Zava, picking up over a million Europe customers
American telehealth company Hims & Hers Health announced on Tuesday that it will be acquiring Zava, a leading European digital health company in an all cash acquisition set to close in the second half of 2025. Following the announcement, Hims' stock price (HIMS) jumped 5.8% in premarket trading.
Which Telehealth Stock Should You Be Targeting?
Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform.
Hims & Hers Expands in Europe With Acquisition of ZAVA
Hims & Hers Health (HIMS) shares rose Tuesday after the health and wellness site announced it was expanding its reach into Europe by buying London-based digital health platform ZAVA. The price of the all-cash deal was not disclosed.
Hims expands into Europe with Zava acquisition
CNBC's Brandon Gomez reports on the latest news regarding Hims.
The Bull Market is Back: 3 Stocks to Buy Now (HIMS, APP, META)
Hims & Hers Health, AppLovin and Meta Platforms all boast a litany of bullish catalysts driving their stock prices higher.
Why Hims & Hers Health, Inc. (HIMS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hims & Hers expands into Europe with Zava acquisition
Hims & Hers (NYSE:HIMS), a leading US-based health and wellness platform, is expanding into Europe via its acquisition of telehealth platform and online pharmacy Zava. The company said the acquisition will expand its footprint in the UK and launch the company in Germany, France and Ireland, with additional markets expected soon.
